Description
REAGENTS
First action · last action
2011-12-22 · 2011-12-22
Transactions
1
First transaction's obligation
$4,365
Base + all options value (sum of deltas)
$4,365
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-12-22+$4,365= $4,365
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-12-22 | +$4,365 | $4,365 | REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI QNXWLAJDL4J3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25223N0138 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $29,500 | FY2023 |
| 36C25222N0460 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,749,821 | FY2022 |
| 36C24922P0526 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $225,000 | FY2022 |
| 36C24122N0069 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $10,146 | FY2022 |
| 36C25221C0111 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $748,050 | FY2021 |
| 36C24121N0154 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $19,957 | FY2021 |
Other recipients under 6550 from 549-DALLAS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25712P0586 | MICROGENICS CORPORATION | 549-DALLAS | $3,370 | FY2012 |
| VA25712J0362 | IMMUCOR INC | 549-DALLAS | $10,614 | FY2012 |
| VA25712J0043 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 549-DALLAS | $24,883 | FY2012 |
| VA25712F0077 | ROCHE DIAGNOSTICS CORPORATION | 549-DALLAS | $29,369 | FY2012 |
| VA549A20058 | IMMUCOR INC | 549-DALLAS | $11,722 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25712P0337_3600_-NONE-_-NONE- · retrieved 2026-09-26.